Summit Therapeutics (SMMT) Net Margin (2019 - 2022)
Summit Therapeutics (SMMT) posted Net Margin of 8014.55% for Q3 2022, down 41.13% on a QoQ basis from 5678.72% in Q2 2022, and down 651730.0% year-over-year from N/an in Q3 2021.
Summit Therapeutics (SMMT) Net Margin (2019 - 2022) Analysis & Trends
Summit Therapeutics' Net Margin history runs 4 years deep, the most recent figure standing at 8014.55% for Q3 2022.
- Quarterly Net Margin fell 651730.0% year-over-year to 8014.55% in Q3 2022, while the trailing twelve-month figure through Jun 2023 was 273511.82% (down 26947769.0% YoY) and the FY2022 annual result came in at 11174.75%, down 627691.0% from the prior year.
- Net Margin was 8014.55% for Q3 2022 at Summit Therapeutics, down from 5678.72% in the prior quarter.
- Across five years, Net Margin topped out at 1497.25% in Q3 2021 and bottomed at 42835.09% in Q2 2021.
- A 4-year average of 9935.3% and a median of 8498.27% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2021 — Net Margin tumbled 3384744 bps — and 2022, when it jumped 3715636 bps.
- Summit Therapeutics' Net Margin stood at 4308.11% in 2019, then slumped by 70 bps to 7319.46% in 2020, then plunged by 48 bps to 10796.41% in 2021, then gained by 26 bps to 8014.55% in 2022.
- Business Quant data shows SMMT's Net Margin at 8014.55% in Q3 2022, 5678.72% in Q2 2022, and 8982.0% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15.02% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 28.20% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -8,014.55% |
| Jun 30, 2022 | -5,678.72% |
| Mar 31, 2022 | -8,982.00% |
| Dec 31, 2021 | -10,796.41% |
| Sep 30, 2021 | -1,497.25% |
| Jun 30, 2021 | -42,835.09% |
| Mar 31, 2021 | -9,108.33% |
| Dec 31, 2020 | -7,319.46% |
| Sep 30, 2020 | -9,802.76% |
| Jun 30, 2020 | -8,987.65% |
| Mar 31, 2020 | -1,893.21% |
| Sep 30, 2019 | -4,308.11% |